Examine research linking reptile-derived peptides and GLP-1–related therapies to potential cartilage repair and osteoarthritis treatment implications.
Key Takeaways
- Preclinical study reported a 17% increase in cartilage volume following GLP-1 agonist treatment
- Small human pilot showed improvements in WOMAC pain and function scores
- Authors cautioned the cartilage gains may be independent of weight loss